Numerous studies have found a positive correlation between obesity and breast cancer incidence, recurrence, and mortality, particularly in postmenopausal patients with estrogen receptor-positive breast cancer, and pre-menopausal triple negative breast cancer (TNBC) ( in vitro and preclinical rodent models
However, when combined with another drug called phentermine as the brand-name drug Qsymia, it is FDA-approved as a weight loss medication for: Adults and pediatric patients aged 12 years and older with obesity (a BMI of 30 or greater) Adults who are overweight (a BMI of 27 or greater) and at least one weight-related condition, like type 2 diabetes or high blood pressure It is important to know that Qsymia is classified as a Schedule IV controlled substance
Eli Lilly announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety & efficacy of Retatrutide, a first-in-class GIP, GLP-1 & glucagon triple hormone receptor agonist, in adults with obesity or overweight & knee osteoarthritis
Freeze water in plastic containers with a couple inches (a few centimeters) of head space, as the expanding ice can break glass or overfilled containers
Consider mild stool softeners or fiber supplements if needed, but check with your healthcare provider first